Breaking News

Parexel COO Wins APCR Honor

By Gil Roth | April 23, 2012

Special Recognition award presented at ACRP conference

Mark A. Goldberg, M.D., chief operating officer of Parexel, has been honored by the Academy of Physicians in Clinical Research (APCR) for his contributions to the advancement of clinical research. He received this year's APCR Special Recognition Award for "his embodiment of APCR's values and for the advancement of clinical research by combining his medical knowledge and development expertise with the application of information technology," according to a Parexel statement.

The awards ceremony and reception took place at the Association of Clinical Research Professionals (ACRP) 2012 Global Conference & Exhibition in Houston, Texas on April 15, 2012. The APCR Special Recognition Award is presented annually to an individual who has demonstrated exceptional performance, achievement and sustained service toward the goals of the APCR, and has made significant contributions to the betterment of the APCR overall.

Dr. Goldberg has served as Parexel's chief operating officer since 2008, and has served on its executive management team for 15 years. In 2000, he was involved in establishing Perceptive Informatics, Parexel's technology subsidiary. Prior to his current role, Dr. Goldberg led strong performance in Clinical Research Services, Parexel's largest business segment, and oversaw the geographic expansion of Parexel's services, including the extension of capabilities in the Asia-Pacific region.

"I am honored by this recognition from the APCR, the leading professional organization dedicated to supporting and addressing the unique issues and challenges of physicians in clinical research," said Dr. Goldberg. "This award is a testament to Parexel's longstanding vision of leveraging information technology to improve efficiency and effectiveness throughout the clinical development process."

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016